PDCD1 and neoplasm: Hayakawa et al. combined curcumin with PD-1/PD-L1 Abs in MC38 murine tumor models and achieved synergistic anti-tumor effects and induced tumor antigen-specific T cells, significantly augmenting the efficacy of treatment 105.